HOME Research Insight Product Launches and Approvals are the Key Growth Strategies Adopted by Market Players in the Protein Binding Assay Market



Product Launches and Approvals are the Key Growth Strategies Adopted by Market Players in the Protein Binding Assay Market


The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market.

Most companies focus on agreements, collaborations, and partnerships to compete in the market. The players also focus on increasing their presence in high-growth markets through acquisitions and product launches. Thermo Fisher (US), Sovicell (Germany) and 3B Pharmaceutical focus on partnerships, collaboration and license agreements to strengthen their position in the market.

In 2017, Thermo Fisher was the leading player in the protein binding assay market. The company has a strong geographic presence across the US, Europe, Greater China, and Asia Pacific. The company focuses on a wide range of products offering in the protein binding assay market. The company’s products are based on the equilibrium dialysis technology, which helps it dominate this market. The company focuses on partnerships to enhance its presence in the market. In 2018, Thermo Fisher partnered with The Montreal Neurological Institute (The Neuro) of the McGill University (Canada) to provide reagents and tools to understand neurological diseases.

To know the Insights download the pdf brochure

HTDialysis is another prominent player in the protein binding assay market. The company offers an extensive portfolio of protein binding products. The company is present in the US, China, Germany, and Japan. With its strong product offerings and geographic presence, the company is expected to garner a major of the market. The company focuses on acquisitions to strengthen its product portfolio. HTDialysis has a strong geographic presence in the countries including Argentina, Australia, Belgium, Brazil, and China.

Some other leading players in the global protein binding assay market are Merck (Germany), Sovicell (Germany) GE Healthcare (US), and Absorption systems (US). These companies focus on product launches, agreements, collaborations, and partnerships to maintain their strong position in the market in the coming years.

Related Reports:

Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports